Content about Anastrozole

July 23, 2012

The Food and Drug Administration has approved a new use for a Novartis cancer drug.

EAST HANOVER, N.J. — The Food and Drug Administration has approved a new use for a Novartis cancer drug.

The drug maker said Friday that the FDA had approved Afinitor (everolimus) combined with exemestane for postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer who have failed treatment with letrozole or anastrozole.

July 8, 2010

Roxane Labs announced Thursday the launch of two new generic drugs....

COLUMBUS, Ohio Roxane Labs announced Thursday the launch of two new generic drugs.

 

The Columbus, Ohio-based generics subsidiary of German drug maker Boehringer Ingelheim, launched naratriptan tablets in the 1-mg and 2.5-mg strengths, and anastrozole tablets in the 1-mg strength.

 

 

June 30, 2010

Anglo-Swedish drug maker AstraZeneca has created a savings card for users of one of its...

June 28, 2010

The Food and Drug Administration has approved two new generic versions of a drug for...